Bidirectional transcription of trinucleotide repeats: Roles for excision repair

DNA Repair

Volumn 12, Issue 8, 2013, Pages 672-684

  Budworth, Helen ^a   McMurray, Cynthia T ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Bidirectional transcription; Coding; Excision repair; Neurodegenerative; RNA transcript; Trinucleotide

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 4; NUCLEAR PROTEIN; NUCLEAR PROTEIN TET1; RNA; THYMINE DNA GLYCOSYLASE; UNCLASSIFIED DRUG;

ARTICLE; BIDIRECTIONAL TRANSCRIPTION; CHROMATIN; DEMETHYLATION; DNA DAMAGE; DNA METHYLATION; EXCISION REPAIR; GENE SILENCING; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HETEROCHROMATIN; HUMAN; NONHUMAN; PRIORITY JOURNAL; TOXICITY; TRINUCLEOTIDE REPEAT;

BIDIRECTIONAL TRANSCRIPTION; CODING; EXCISION REPAIR; NEURODEGENERATIVE; RNA TRANSCRIPT; TRINUCLEOTIDE;

ANIMALS; CHROMATIN; DISEASE MODELS, ANIMAL; DNA; DNA DAMAGE; DNA REPAIR; FRAGILE X SYNDROME; GENE SILENCING; GENOMIC INSTABILITY; HUMANS; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84880577665     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2013.04.019     Document Type: Article

References (158)

1. McMurray C.T. Mechanisms of trinucleotide repeat instability during human development. Nat. Rev. Genet. 2010, 11(11):786-799.
2. La Spada A.R., Taylor J.P. Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat. Rev. Genet. 2010, 11(4):247-258.
3. Dion V., Wilson J.H. Instability and chromatin structure of expanded trinucleotide repeats. Trends Genet. 2009, 25(7):288-297.
4. Zoghbi H.Y., Orr H.T. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J. Biol. Chem. 2009, 284(12):7425-7429.
5. Imarisio S., et al. Huntington's disease: from pathology and genetics to potential therapies. Biochem. J. 2008, 412(2):191-209.
6. Messaed C., Rouleau G.A. Molecular mechanisms underlying polyalanine diseases. Neurobiol. Dis. 2009, 34(3):397-405.
7. Trinklein N.D., et al. An abundance of bidirectional promoters in the human genome. Genome Res. 2004, 14(1):62-66.
8. He Y., et al. The antisense transcriptomes of human cells. Science 2008, 322(5909):1855-1857.
9. Ikeda Y., Daughters R.S., Ranum L.P. Bidirectional expression of the SCA8 expansion mutation: one mutation, two genes. Cerebellum 2008, 7(2):150-158.
10. Batra R., Charizanis K., Swanson M.S. Partners in crime: bidirectional transcription in unstable microsatellite disease. Hum. Mol. Genet. 2010, 19(R1):R77-R82.
11. Nakamori M., Pearson C.E., Thornton C.A. Bidirectional transcription stimulates expansion and contraction of expanded (CTG)*(CAG) repeats. Hum. Mol. Genet. 2011, 20(3):580-588.
12. Zu T., et al. Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(1):260-265.
13. Pearson C.E. Repeat associated non-ATG translation initiation: one DNA, two transcripts, seven reading frames, potentially nine toxic entities!. PLoS Genet. 2011, 7(3):e1002018.
14. Cho D.H., et al. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol. Cell 2005, 20(3):483-489.
15. Wilburn B., et al. An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice. Neuron 2011, 70(3):427-440.
16. Ladd P.D., et al. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet. 2007, 16(24):3174-3187.
17. Chung D.W., et al. A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression. Hum. Mol. Genet. 2011, 20(17):3467-3477.
18. Sopher B.L., et al. CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA. Neuron 2011, 70(6):1071-1084.
19. Cortellino S., et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 2011, 146(1):67-79.
20. Cortazar D., et al. Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature 2011, 470(7334):419-423.
21. Le May N., et al. NER factors are recruited to active promoters and facilitate chromatin modification for transcription in the absence of exogenous genotoxic attack. Mol. Cell 2010, 38(1):54-66.
22. Timchenko N.A., et al. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem. 2001, 276(11):7820-7826.
23. de Haro M., et al. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1. Hum. Mol. Genet. 2006, 15(13):2138-2145.
24. Pascual M., et al. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation 2006, 74(2/3):65-80.
25. Kino Y., et al. MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res. 2009, 37(19):6477-6490.
26. Du H., et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 2010, 17(2):187-193.
27. Suenaga K., et al. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. PLoS ONE 2012, 7(3):e33218.
28. Llamusi B., Artero R. Molecular effects of the CTG repeats in mutant Dystrophia Myotonica protein kinase gene. Curr. Genomics 2008, 9(8):509-516.
29. Margolis R.L., Rudnicki D.D., Holmes S.E. Huntington's disease like-2: review and update. Acta Neurol. Taiwan. 2005, 14(1):1-8.
30. Greenstein P.E., et al. Huntington's disease like-2 neuropathology. Mov. Disord. 2007, 22(10):1416-1423.
31. Rudnicki D.D., et al. A comparison of huntington disease and huntington disease-like 2 neuropathology. J. Neuropathol. Exp. Neurol. 2008, 67(4):366-374.
32. Holmes S.E., et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat. Genet. 2001, 29(4):377-378.
33. Koob M.D., et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat. Genet. 1999, 21(4):379-384.
34. Moseley M.L., et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat. Genet. 2006, 38(7):758-769.
35. Mutsuddi M., et al. The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Curr. Biol. 2004, 14(4):302-308.
36. Daughters R.S., et al. RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet. 2009, 5(8):e1000600.
37. He Y., et al. Targeted deletion of a single Sca8 ataxia locus allele in mice causes abnormal gait, progressive loss of motor coordination, and Purkinje cell dendritic deficits. J. Neurosci. 2006, 26(39):9975-9982.
38. Cernilogar F.M., et al. Chromatin-associated RNA interference components contribute to transcriptional regulation in Drosophila. Nature 2011, 480(7377):391-395.
39. Yu Z., Teng X., Bonini N.M. Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy. PLoS Genet. 2011, 7(3):e1001340.
40. Miller J.W., et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 2000, 19(17):4439-4448.
41. Filippova G.N., et al. CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat. Genet. 2001, 28(4):335-343.
42. Brook J.D., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 68(4):799-808.
43. Jansen G., et al. Physical and genetic characterization of the distal segment of the myotonic dystrophy area on 19q. Genomics 1992, 13(3):509-517.
44. Mahadevan M., et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3'untranslated region of the gene. Science 1992, 255(5049):1253-1255.
45. Trojer P., Reinberg D. Facultative heterochromatin: is there a distinctive molecular signature?. Mol. Cell 2007, 28(1):1-13.
46. Wutz A. Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat. Rev. Genet. 2011, 12(8):542-553.
47. Barr M.L., Carr D.H. Correlations between sex chromatin and sex chromosomes. Acta Cytol. 1962, 6:34-45.
48. Belmont A.S., Bignone F., Ts'o P.O. The relative intranuclear positions of Barr bodies in XXX non-transformed human fibroblasts. Exp. Cell Res. 1986, 165(1):165-179.
49. Puck T.T., Johnson R. DNA exposure and condensation in the X and 21 chromosomes. Stem Cells 1996, 14(5):548-557.
50. Hall L.L., Lawrence J.B. XIST RNA and architecture of the inactive X chromosome: implications for the repeat genome. Cold Spring Harb. Symp. Quant. Biol. 2010, 75:345-356.
51. Pinter S.F., et al. Spreading of X chromosome inactivation via a hierarchy of defined Polycomb stations. Genome Res. 2012, 22:1864-1876.
52. Pontier D.B., Gribnau J. Xist regulation and function explored. Hum. Genet. 2011, 130(2):223-236.
53. Handa V., Saha T., Usdin K. The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer. Nucleic Acids Res. 2003, 31(21):6243-6248.
54. Lin S.L., Chang S.J., Ying S.Y. First in vivo evidence of microRNA-induced fragile X mental retardation syndrome. Mol. Psychiatry 2006, 11(7):616-617.
55. Krol J., et al. Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol. Cell 2007, 25(4):575-586.
56. Lin S.L., Miller J.D., Ying S.Y. Intronic microRNA (miRNA). J. Biomed. Biotechnol. 2006, 2006(4):26818.
57. Lin S.L., Kim H., Ying S.Y. Intron-mediated RNA interference and microRNA (miRNA). Front. Biosci. 2008, 13:2216-2230.
58. Lin S.L., et al. A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution. Biochem. Biophys. Res. Commun. 2003, 310(3):754-760.
59. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
60. Yi R., et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17(24):3011-3016.
61. Lund E., et al. Nuclear export of microRNA precursors. Science 2004, 303(5654):95-98.
62. Lin S.L., Chang D., Ying S.Y. Asymmetry of intronic pre-miRNA structures in functional RISC assembly. Gene 2005, 356:32-38.
63. Czech B., Hannon G.J. Small RNA sorting: matchmaking for Argonautes. Nat. Rev. Genet. 2011, 12(1):19-31.
64. Creamer K.M., Partridge J.F. RITS-connecting transcription, RNA interference, and heterochromatin assembly in fission yeast. Wiley Interdiscip. Rev. RNA 2011, 2(5):632-646.
65. Schwarz D.S., et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115(2):199-208.
66. Khvorova A., Reynolds A., Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115(2):209-216.
67. Bernstein E., Allis C.D. RNA meets chromatin. Genes Dev. 2005, 19(14):1635-1655.
68. Kawasaki H., Taira K. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 2004, 431(7005):211-217.
69. Morris K.V., et al. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004, 305(5688):1289-1292.
70. Dernburg A.F., et al. Perturbation of nuclear architecture by long-distance chromosome interactions. Cell 1996, 85(5):745-759.
71. Haber J.E. Mating-type genes and MAT switching in Saccharomyces cerevisiae. Genetics 2012, 191(1):33-64.
72. Burgess-Beusse B., et al. The insulation of genes from external enhancers and silencing chromatin. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(Suppl. 4):16433-16437.
73. Otten A.D., Tapscott S.J. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl. Acad. Sci. U.S.A. 1995, 92(12):5465-5469.
74. Philips A.V., Timchenko L.T., Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998, 280(5364):737-741.
75. Kumari D., Usdin K. The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum. Mol. Genet. 2010, 19(23):4634-4642.
76. Wegel E., Shaw P. Gene activation and deactivation related changes in the three-dimensional structure of chromatin. Chromosoma 2005, 114(5):331-337.
77. Gilbert N., Bickmore W.A. The relationship between higher-order chromatin structure and transcription. Biochem. Soc. Symp. 2006, (73):59-66.
78. Gilbert N., et al. Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers. Cell 2004, 118(5):555-566.
79. Garden G.A., La Spada A.R. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration. Cerebellum 2008, 7(2):138-149.
80. Libby R.T., et al. CTCF cis-regulates trinucleotide repeat instability in an epigenetic manner: a novel basis for mutational hot spot determination. PLoS Genet. 2008, 4(11):e1000257.
81. Kovtun I.V., et al. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 2007, 447(7143):447-452.
82. Johri A., Beal M.F. Antioxidants in Huntington's disease. Biochim. Biophys. Acta 2012, 1822(5):664-674.
83. Liu Y., Wilson S.H. DNA base excision repair: a mechanism of trinucleotide repeat expansion. Trends Biochem. Sci. 2012, 37(4):162-172.
84. Quintanilla R.A., Johnson G.V. Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Res. Bull. 2009, 80(4/5):242-247.
85. Ferguson L.R. Chronic inflammation and mutagenesis. Mutat. Res. 2010, 690(1/2):3-11.
86. Doyle K.M., et al. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J. Cell. Mol. Med. 2011, 15(10):2025-2039.
87. Pan Y. Mitochondria, reactive oxygen species, and chronological aging: a message from yeast. Exp. Gerontol. 2011, 46(11):847-852.
88. Mollersen L., et al. Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice. Hum. Mol. Genet. 2012, 21:4939-4947.
89. Salinas-Rios V., Belotserkovskii B.P., Hanawalt P.C. DNA slip-outs cause RNA polymerase II arrest in vitro: potential implications for genetic instability. Nucleic Acids Res. 2011, 39(17):7444-7454.
90. Kovtun I.V., Johnson K.O., McMurray C.T. Cockayne syndrome B protein antagonizes OGG1 in modulating CAG repeat length in vivo. Aging (Milano) 2011, 3(5):509-514.
91. Hubert L., et al. Xpa deficiency reduces CAG trinucleotide repeat instability in neuronal tissues in a mouse model of SCA1. Hum. Mol. Genet. 2011, 20(24):4822-4830.
92. Hegde M.L., Hazra T.K., Mitra S. Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells. Cell Res. 2008, 18(1):27-47.
93. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993, 362(6422):709-715.
94. Lindahl T. DNA glycosylases in DNA repair. Basic Life Sci. 1986, 38:335-340.
95. Lindahl T. DNA repair enzymes. Annu. Rev. Biochem. 1982, 51:61-87.
96. Jacobs A.L., Schar P. DNA glycosylases: in DNA repair and beyond. Chromosoma 2012, 121(1):1-20.
97. Wang Y., et al. Transcriptional inhibition by an oxidized abasic site in DNA. Chem. Res. Toxicol. 2006, 19(2):234-241.
98. Brooks P.J. The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair (Amst.) 2008, 7(7):1168-1179.
99. You C., et al. A quantitative assay for assessing the effects of DNA lesions on transcription. Nat. Chem. Biol. 2012, 8:817-822.
100. Kim N., Jinks-Robertson S. Abasic sites in the transcribed strand of yeast DNA are removed by transcription-coupled nucleotide excision repair. Mol. Cell. Biol. 2010, 30(13):3206-3215.
101. Fagbemi A.F., Orelli B., Scharer O.D. Regulation of endonuclease activity in human nucleotide excision repair. DNA Repair (Amst.) 2011, 10(7):722-729.
102. Staresincic L., et al. Coordination of dual incision and repair synthesis in human nucleotide excision repair. EMBO J. 2009, 28(8):1111-1120.
103. Volker J., et al. Energy landscapes of dynamic ensembles of rolling triplet repeat bulge loops: implications for DNA expansion associated with disease states. J. Am. Chem. Soc. 2012, 134(13):6033-6044.
104. Dragileva E., et al. Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes. Neurobiol. Dis. 2009, 33(1):37-47.
105. Newman J.C., Bailey A.D., Weiner A.M. Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(25):9613-9618.
106. Jung J., Bonini N. CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. Science 2007, 315(5820):1857-1859.
107. Lin Y., Hubert L., Wilson J.H. Transcription destabilizes triplet repeats. Mol. Carcinog. 2009, 48(4):350-361.
108. Lin Y., Wilson J.H. Transcription-induced CAG repeat contraction in human cells is mediated in part by transcription-coupled nucleotide excision repair. Mol. Cell. Biol. 2007, 27(17):6209-6217.
109. Kovtun I.V., McMurray C.T. Crosstalk of DNA glycosylases with pathways other than base excision repair. DNA Repair (Amst.) 2007, 6(4):517-529.
110. Slupphaug G., Kavli B., Krokan H.E. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat. Res. 2003, 531(1/2):231-251.
111. Wong H.K., et al. Cockayne syndrome B protein stimulates apurinic endonuclease 1 activity and protects against agents that introduce base excision repair intermediates. Nucleic Acids Res. 2007, 35(12):4103-4113.
112. Thorslund T., et al. Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress. Mol. Cell. Biol. 2005, 25(17):7625-7636.
113. Hagerman R.J., et al. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am. J. Med. Genet. 1994, 51(4):298-308.
114. Smeets H.J., et al. Normal phenotype in two brothers with a full FMR1 mutation. Hum. Mol. Genet. 1995, 4(11):2103-2108.
115. Pietrobono R., et al. Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum. Mol. Genet. 2005, 14(2):267-277.
116. Chiurazzi P., et al. In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Hum. Mol. Genet. 1998, 7(1):109-113.
117. Coffee B., et al. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 1999, 22(1):98-101.
118. Pietrobono R., et al. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res. 2002, 30(14):3278-3285.
119. Tabolacci E., et al. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Eur. J. Hum. Genet. 2005, 13(5):641-648.
120. Sedgwick B., et al. Repair of alkylated DNA: recent advances. DNA Repair (Amst.) 2007, 6(4):429-442.
121. Maiti A., et al. Crystal structure of human thymine DNA glycosylase bound to DNA elucidates sequence-specific mismatch recognition. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(26):8890-8895.
122. Ooi S.K., Bestor T.H. The colorful history of active DNA demethylation. Cell 2008, 133(7):1145-1148.
123. Rai K., et al. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 2008, 135(7):1201-1212.
124. Zhu B., et al. Overexpression of 5-methylcytosine DNA glycosylase in human embryonic kidney cells EcR293 demethylates the promoter of a hormone-regulated reporter gene. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(9):5031-5036.
125. Jost J.P., et al. 5-Methylcytosine DNA glycosylase participates in the genome-wide loss of DNA methylation occurring during mouse myoblast differentiation. Nucleic Acids Res. 2001, 29(21):4452-4461.
126. Metivier R., et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452(7183):45-50.
127. Cortazar D., et al. The enigmatic thymine DNA glycosylase. DNA Repair (Amst.) 2007, 6(4):489-504.
128. Hardeland U., et al. Thymine DNA glycosylase. Prog. Nucleic Acid Res. Mol. Biol. 2001, 68:235-253.
129. Sanz L.A., Kota S.K., Feil R. Genome-wide DNA demethylation in mammals. Genome Biol. 2010, 11(3):110.
130. Anant S., et al. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J. Biol. Chem. 2001, 276(50):47338-47351.
131. Morgan H.D., et al. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem. 2004, 279(50):52353-52360.
132. Pena-Diaz J., Jiricny J. Mammalian mismatch repair: error-free or error-prone?. Trends Biochem. Sci. 2012, 37(5):206-214.
133. Rechkunova N.I., Lavrik O.I. Nucleotide excision repair in higher eukaryotes: mechanism of primary damage recognition in global genome repair. Subcell. Biochem. 2010, 50:251-277.
134. Waters T.R., Swann P.F. Thymine-DNA glycosylase and G to A transition mutations at CpG sites. Mutat. Res. 2000, 462(2/3):137-147.
135. Hang B., Guliaev A.B. Substrate specificity of human thymine-DNA glycosylase on exocyclic cytosine adducts. Chem. Biol. Interact. 2007, 165(3):230-238.
136. Smith K.T., Coffee B., Reines D. Occupancy and synergistic activation of the FMR1 promoter by Nrf-1 and Sp1 in vivo. Hum. Mol. Genet. 2004, 13(15):1611-1621.
137. Lim J.H., et al. AP-2alpha selectively regulates fragile X mental retardation-1 gene transcription during embryonic development. Hum. Mol. Genet. 2005, 14(14):2027-2034.
138. Smith K.T., Nicholls R.D., Reines D. The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors. Nucleic Acids Res. 2006, 34(4):1205-1215.
139. Carrillo C., Cisneros B., Montanez C. Sp1 and AP2 transcription factors are required for the human fragile mental retardation promoter activity in SK-N-SH neuronal cells. Neurosci. Lett. 1999, 276(3):149-152.
140. Tini M., et al. Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription. Mol. Cell 2002, 9(2):265-277.
141. Mohan R.D., et al. SUMO-1-dependent allosteric regulation of thymine DNA glycosylase alters subnuclear localization and CBP/p300 recruitment. Mol. Cell. Biol. 2007, 27(1):229-243.
142. Chen D., et al. T:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor alpha. J. Biol. Chem. 2003, 278(40):38586-38592.
143. Xiao W., et al. Imprinting of the MEA Polycomb gene is controlled by antagonism between MET1 methyltransferase and DME glycosylase. Dev. Cell 2003, 5(6):891-901.
144. Penterman J., Uzawa R., Fischer R.L. Genetic interactions between DNA demethylation and methylation in Arabidopsis. Plant Physiol. 2007, 145(4):1549-1557.
145. Tahiliani M., et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324(5929):930-935.
146. Koh K.P., et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011, 8(2):200-213.
147. Ito S., et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333(6047):1300-1303.
148. Ito S., et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466(7310):1129-1133.
149. Williams K., Christensen J., Helin K. DNA methylation: TET proteins-guardians of CpG islands?. EMBO Rep. 2012, 13(1):28-35.
150. Tan L., Shi Y.G. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 2012, 139(11):1895-1902.
151. Wu H., Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 2011, 25(23):2436-2452.
152. Guo J.U., et al. Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond. Cell Cycle 2011, 10(16):2662-2668.
153. Branco M.R., Ficz G., Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat. Rev. Genet. 2012, 13(1):7-13.
154. Williams K., et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473(7347):343-348.
155. Wu H., et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 2011, 473(7347):389-393.
156. Xu Y., et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell 2011, 42(4):451-464.
157. Globisch D., et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS ONE 2010, 5(12):e15367.
158. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324(5929):929-930.